Phase
Condition
Congenital Heart Disease
Pentalogy Of Cantrell
Heart Disease
Treatment
Pulmonary Valve Replacement Surgery
Clinical Study ID
Ages 18-16 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Candidates must meet all of the following inclusion criteria to be considered for enrollment in this study.
Age 18 months to 16 years.
Male or female.
Subject has a native or repaired right ventricular outflow tract.
Subject has been recommended for surgical pulmonary valve replacement by treatingclinical team (cardiologist and cardiac surgeon).
Subject has at least one of the following echocardiographic findings:
Severe pulmonary stenosis (defined as RV to PA peak instantaneous gradient ≥60mmHg);
Moderate or greater pulmonary regurgitation;
Moderate or greater pulmonary stenosis plus moderate or greater pulmonaryregurgitation.
Subject's body size is suitable for implantation of a study device ranging from 12.7to 22 mm (internal diameter).
Subject and parent/legal representative, where appropriate, are willing to provideinformed written consent.
Subject and parent/legal representative, where appropriate, and treating physicianagree that the subject will return for, and comply with, all required studyassessments and follow-up visits.
Exclusion
Exclusion Criteria:
Candidates will be excluded from the study if any of the following conditions are met:
Subject requires valve replacement in a non-pulmonary position.
Subject has a prosthetic valve at other valve position or will need a prostheticvalve at other valve position (i.e., anticipate additional valve replacements neededwithin 3 years).
Subject has pulmonary arterial hypertension (defined as mean PA pressure ≥25 mmHg).
Subject has pulmonary atresia and major aortopulmonary collaterals.
Subject has significant peripheral pulmonary artery stenosis.
Subject has an active infection requiring current systemic antibiotic therapy (iftemporary illness, subject may be a candidate 4 weeks after discontinuation ofantibiotics).
Subject has active endocarditis or a history of infective endocarditis.
Subject has renal insufficiency as determined by a serum creatinine (S-Cr) level ≥2.5 mg/dL within 60 days prior to the Screening Visit, or has end-stage renaldisease.
Subject has leukopenia (defined as a white blood cell (WBC) count <3.5 x 103/µL)
Subject has acute or chronic anemia (defined as hemoglobin (Hgb) <10.0 g/dl or 6mmol/L).
Subject has thrombocytopenia (defined as platelet count <50 x 103/µL.
Subject has a known hypersensitivity to anticoagulants and antiplatelet drugs.
Subject has a known autoimmune disease or receives immunosuppressant and/orimmunostimulant drugs that the Investigator or Eligibility Screening Committee (ESC)believes may negatively affect study outcomes.
Subject needs emergency cardiac or vascular surgery or intervention.
Positive pregnancy test prior to valve implant procedure in female subjects who havehad their first menses.
Subject has, in the opinion of the Investigator, a life expectancy of less than 5years.
Subject or parent/legal representative refuses blood transfusions.
Subject has medical, social or psychosocial factors that, in the opinion of theInvestigator or ESC, could impact safety or compliance with study procedures.
Subject is participating in an investigational study of a new drug, biologic ordevice at the time of study screening.
Study Design
Connect with a study center
Children's Hospital Los Angeles
Los Angeles, California 90027
United StatesActive - Recruiting
Children's Hospital Colorado
Aurora, Colorado 80045
United StatesActive - Recruiting
Children's Healthcare of Atlanta
Atlanta, Georgia 30322
United StatesActive - Recruiting
Ann and Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois 60611
United StatesActive - Recruiting
Boston Children's Hospital
Boston, Massachusetts 02115
United StatesActive - Recruiting
University of Michigan - Mott Children's Hospital
Ann Arbor, Michigan 48109
United StatesActive - Recruiting
Columbia University Irving Medical Center/New York Presbyterian Morgan Stanley Children's Hospital
New York, New York 10032
United StatesActive - Recruiting
Duke University
Durham, North Carolina 27703
United StatesActive - Recruiting
Nationwide Children's Hospital
Columbus, Ohio 43205
United StatesActive - Recruiting
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania 19104
United StatesActive - Recruiting
University of Utah - Intermountain Primary Children's Hospital
Salt Lake City, Utah 84113
United StatesActive - Recruiting
Seattle Children's Hospital
Seattle, Washington 98105
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.